Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-9801 in Diabetic Neuropathy
NCT01822925Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Nov 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DA-9801 in diabetic peripheral neuropathy (DPN), sponsored by NeuroBo Pharmaceuticals. Started Nov 2013; status: completed.
02
Drugs
DA-9801
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01822925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822925.